Salicylic acid

Description

The product is identified by the SPL code 34089-3 and is formulated as a skin tag remover patch. Each patch contains 1 milligram (1 MB) of the active ingredient. The package includes a total of 144 patches, designed for effective application in the removal of skin tags.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. However, the precise indications and usage have not been explicitly stated in the provided information.

Healthcare professionals are advised to consider the absence of information regarding teratogenic and nonteratogenic effects when prescribing this medication. Further clinical evaluation and consultation of relevant guidelines are recommended to ensure appropriate use in targeted patient populations.

Dosage and Administration

The recommended dosage for the patch is to be applied topically. Healthcare professionals should ensure that the patch is placed on clean, dry, and intact skin. It is important to select a site that is free from hair and irritation to enhance adhesion and effectiveness.

The patch should be applied once daily, and it is crucial to rotate the application site to minimize skin irritation. If a patch becomes dislodged or falls off, it should be replaced with a new patch as soon as possible.

Patients should be instructed to avoid applying the patch to the same site for at least 7 days to prevent skin sensitization. Additionally, the patch should not be cut or altered in any way prior to application.

Monitoring for efficacy and any potential adverse reactions is recommended following the initiation of therapy.

Contraindications

Use is contraindicated on damaged or broken skin due to the potential for adverse effects and compromised healing. No other contraindications have been specified.

Warnings and Precautions

To avoid the risk of suffocation, it is imperative to keep this plastic bag away from infants and children. This bag should not be used in cribs, beds, carriages, or playpens, as it poses a significant hazard. It is important to note that this bag is not a toy and should be treated with caution.

In the event of accidental ingestion, immediate medical assistance is required. Healthcare professionals should advise patients to seek emergency medical help or contact a Poison Control Center without delay.

Patients should discontinue use and consult their healthcare provider if they experience any rash or irritation. Prompt communication with a physician is essential to address any adverse reactions effectively.

Side Effects

Patients should be aware of the potential risks associated with the use of this product. There is a warning regarding the danger of suffocation; therefore, it is imperative to keep the plastic bag away from babies and children. The bag should not be used in cribs, beds, carriages, or playpens, as it is not a toy.

In the event that a rash and/or irritation occurs, patients are advised to stop using the product immediately and consult a doctor.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Skin Tag Remover Patches. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when using this product due to safety concerns. The plastic bag poses a suffocation risk; therefore, it must be kept away from infants and children. It is imperative that this bag is not used in cribs, beds, carriages, or playpens, as it is not a toy.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised. Caregivers should ensure that the product is kept out of reach of children to prevent any potential hazards.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy. Current data does not indicate any safety concerns related to pregnancy. Additionally, no dosage modifications are specified for pregnant individuals, and no special precautions are noted for use during this period. Healthcare professionals should consider the absence of data when prescribing this medication to pregnant patients and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, no dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function are specified in the prescribing information. Healthcare professionals should exercise caution and consider the individual patient's liver function when prescribing this medication.

Overdosage

In the context of overdosage, it is important to note that there is currently no information available regarding the effects or management of an overdose for this medication. Healthcare professionals are advised to exercise caution and consider the absence of specific overdosage data when prescribing or administering this treatment.

In the event of suspected overdosage, it is recommended that healthcare providers monitor the patient closely for any adverse effects and provide supportive care as necessary. Additionally, consultation with a poison control center or a medical toxicologist may be warranted to ensure appropriate management strategies are employed.

Given the lack of detailed information, further research and clinical experience may be necessary to establish a comprehensive understanding of potential overdosage scenarios and their implications.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to emphasize that the product should not be applied to damaged or broken skin to prevent potential complications.

Patients should be instructed to discontinue use and consult a healthcare professional if they experience any rash or irritation while using the product. Additionally, providers should remind patients to avoid contact with the eyes during application and to rinse thoroughly with water if the product comes into contact with the eyes.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature to maintain its integrity and effectiveness. It is essential to keep the product out of reach of children to prevent accidental ingestion. Additionally, once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Skin Tag Remover Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)